Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Auditor change
Inv. presentation
Acq. announced
Director departure
Appointed director
Emmaus Life Sciences, Inc. (MYND) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/04/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/23/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Emmaus Life Sciences Reports Management Changes"
08/14/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Emmaus Life Sciences Reports Q2 2023 Financial Results"
05/15/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Emmaus Life Sciences Reports Q1 2023 Financial Results and Provides Business Update Torrance CA, May 15, 2023 - Emmaus Life Sciences, Inc. , a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported on its financial condition and results of operations as of and for the three months ended March 31, 2023. Recent Highlights “We enjoyed a fifth straight increase in quarterly net revenues and increased net revenues of 109% year-over-year on the strength of increased sales in the U.S. and the Middle East North Africa region. As a result, we were able to substantially reduce loss from operations and realized income from operations excluding share-based compensation. We hope to build on this momentum and achieve income from operations in the co..."
03/31/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Emmaus Life Sciences Reports 2022 Financial Results and Provides Business Update"
01/19/2023 8-K Unregistered Sales of Equity Securities, Departure of Directors or Certain Officers; Election of Directors; Appointment of Ce...
12/09/2022 8-K Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits  Interactive Data
11/14/2022 8-K Quarterly results
10/06/2022 8-K Quarterly results
09/30/2022 8-K Resignation/termination of a director
08/19/2022 8-K Quarterly results
08/15/2022 8-K Quarterly results
08/10/2022 8-K Quarterly results
06/10/2022 8-K Quarterly results
05/13/2022 8-K Quarterly results
03/31/2022 8-K Quarterly results
Docs: "Emmaus Life Sciences, Inc. Condensed Consolidated Statement of Operations and Comprehensive Income Year Ended December 31 2021 2020 Revenues, Net $ 20,610 $ 23,167 Cost of Goods Sold 3,312 2,248 Gross Profit 17,298 20,919 Operating Expenses 23,426 20,951 Loss from Operations Total Other Income 1,005 Net Income 1,354 Comprehensive Income 2,577 Earnings per Share $ $ 0.03 Weighted Average Common Shares Outstanding 49,253,156 48,897,004 4 Emmaus Life Sciences, Inc. Condensed Consolidated Balance Sheets"
01/10/2022 8-K Appointed a new director
11/29/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
10/12/2021 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Emmaus Life Sciences Acquires Key Intellectual Property Rights to Novel IRAK4 Inhibitor From Kainos Medicine"
08/09/2021 8-K Quarterly results
05/19/2021 8-K Quarterly results
02/22/2021 8-K Quarterly results
02/16/2021 8-K Quarterly results
11/13/2020 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Loan Agreement between Emmaus Life Sciences, Inc. and EJ Holdings, Inc"
10/29/2020 8-K Investor presentation
Docs: "Company presentation at September 17, 2020 virtual stockholders informational meeting"
10/20/2020 8-K Entry into a Material Definitive Agreement
09/24/2020 8-K Quarterly results
09/17/2020 8-K Changes in Registrant's Certifying Accountant
09/01/2020 8-K Quarterly results
07/31/2020 8-K Quarterly results
07/08/2020 8-K Quarterly results
03/27/2020 8-K Other Events
03/03/2020 8-K Quarterly results
02/27/2020 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy